Chen‐Chun Lin

1.7k total citations
36 papers, 1.1k citations indexed

About

Chen‐Chun Lin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Chen‐Chun Lin has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 13 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Chen‐Chun Lin's work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Chen‐Chun Lin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Liver Disease Diagnosis and Treatment (9 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Chen‐Chun Lin collaborates with scholars based in Taiwan, United States and Philippines. Chen‐Chun Lin's co-authors include Shi‐Ming Lin, Yi‐Cheng Chen, Chao‐Wei Hsu, Chun‐Jung Lin, Wei‐Ting Chen, Jaw‐Ching Wu, Chun‐Jung Lin, Shi‐Ming Lin, Wen‐Juei Jeng and Chau‐Ting Yeh and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Chen‐Chun Lin

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by Chen‐Chun Lin

Since Specialization

Citations

This map shows the geographic impact of Chen‐Chun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Chun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Chun Lin more than expected).

Fields of papers citing papers by Chen‐Chun Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Chun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Chun Lin. The network helps show where Chen‐Chun Lin may publish in the future.

Co-authorship network of co-authors of Chen‐Chun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Chun Lin. A scholar is included among the top collaborators of Chen‐Chun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Chun Lin. Chen‐Chun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Subsequent locoregional therapy prolongs survival in progressive hepatocellular carcinoma patients under lenvatinib treatment 2024 ·Journal of the Formosan Medical Association ·(unknown), Wei Teng, Wen‐Juei Jeng, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen	2
2	A combination of locoregional treatment with systemic therapy after atezolizumab plus bevacizumab failure for unresectable hepatocellular carcinoma provides survival benefit. 2023 ·PubMed ·(unknown), Wei Teng, (unknown), Tsung‐Han Wu, (unknown), (unknown), Chien‐Hao Huang, Wei‐Ting Chen, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin	1
3	GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial 2022 ·Hepatology International ·Wei‐Ting Chen, Shi‐Ming Lin, Wei‐Chen Lee, Ting-Jung Wu, Chen‐Chun Lin, Chien‐Heng Shen, Ming‐Ling Chang, Chih‐Lang Lin, Chau‐Ting Yeh	11
4	Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma 2022 ·Cancer Medicine ·(unknown), Wei Teng, (unknown), Wen‐Juei Jeng, (unknown), (unknown), Wei‐Ting Chen, (unknown), Chia‐Hsun Hsieh, (unknown), (unknown), Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin	17
5	Pneumomediastinum and Tension Pneumoperitoneum following Bronchioloalveolar lavage in a mechanically ventilated patient 2021 ·Respiratory Medicine Case Reports ·(unknown), (unknown), (unknown), Chen‐Chun Lin	2
6	Real-world outcomes of first- and second-generation tyrosine kinase inhibitors first-line in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: A retrospective observational cohort study 2021 ·PLoS ONE ·(unknown), Chen‐Chun Lin, Ching‐Yuan Cheng, (unknown), Shang‐Jyh Kao, Diana Yeh	6
7	Real-time virtual sonography-assisted radiofrequency ablation in liver tumors with conspicuous or inconspicuous images or peritumoral landmarks under ultrasonography 2021 ·Abdominal Radiology ·(unknown), (unknown), (unknown), Wei‐Ting Chen, Chen‐Chun Lin, Shi‐Ming Lin	6
8	Postembolization fever after transarterial chemoembolization is a sign of unfavorable therapeutic response in hepatocellular carcinoma patients 2020 ·Advances in digestive medicine ·(unknown), Wei Teng, (unknown), Wen‐Juei Jeng, Chien‐Hao Huang, Kar‐Wai Lui, (unknown), Yi‐Cheng Chen, Chen‐Chun Lin, (unknown), Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen	2
9	Functional Genomics Identifies Hepatitis-Induced STAT3–TYRO3–STAT3 Signaling as a Potential Therapeutic Target of Hepatoma 2019 ·Clinical Cancer Research ·(unknown), (unknown), Ming‐Chin Yu, (unknown), Tse‐Ching Chen, Wen‐Yu Chuang, (unknown), Chen‐Chun Lin, Shi‐Ming Lin, Sen‐Yung Hsieh	13
10	A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy 2019 ·The Pharmacogenomics Journal ·Chen‐Chun Lin, Chao‐Wei Hsu, Yi‐Cheng Chen, Ming‐Ling Chang, Kung‐Hao Liang, Ming‐Wei Lai, Chih‐Lang Lin, Rong‐Nan Chien, Kwang‐Huei Lin, Chau‐Ting Yeh	10
11	The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients 2019 ·Journal of the Formosan Medical Association ·(unknown), Wei Teng, Wen‐Juei Jeng, (unknown), (unknown), Chien‐Hao Huang, Kar‐Wai Lui, Yi‐Cheng Chen, Chen‐Chun Lin, Shi‐Ming Lin, I‐Shyan Sheen, Chun‐Yen Lin	4
12	Nomogram predicting extrahepatic metastasis of hepatocellular carcinoma based on commonly available clinical data 2018 ·JGH Open ·(unknown), Chee‐Jen Chang, Yu‐Jr Lin, (unknown), Chien‐Heng Shen, (unknown), Chen‐Chun Lin, Sen‐Yung Hsieh	12
13	A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib 2018 ·Asia-Pacific Journal of Clinical Oncology ·Yu‐De Chu, Kwang‐Huei Lin, Ya‐Hui Huang, Chen‐Chun Lin, Chien‐Fu Hung, Ta‐Sen Yeh, Wei‐Chen Lee, Chau‐Ting Yeh	8
14	Combining radiofrequency ablation and ethanol injection may achieve comparable long‐term outcomes in larger hepatocellular carcinoma (3.1–4 cm) and in high‐risk locations 2014 ·The Kaohsiung Journal of Medical Sciences ·(unknown), Chen‐Chun Lin, Wei‐Ting Chen, Shi‐Ming Lin	13
15	Fine‐needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades 2007 ·Journal of Gastroenterology and Hepatology ·Chen‐Chun Lin, Chun‐Jung Lin, Chao‐Wei Hsu, Yi‐Cheng Chen, Wei‐Ting Chen, Shi‐Ming Lin	10
16	A Novel Ex Vivo Assay of Interferon‐Based Suppression, to Predict the Outcome of Antiviral Therapy for Hepatitis C 2006 ·The Journal of Infectious Diseases ·Chau‐Ting Yeh, Chao‐Wei Hsu, Ming‐Ling Chang, I‐Shyan Sheen, Shi‐Ming Lin, Chun‐Jung Lin, Chen‐Chun Lin, Yi‐Cheng Chen, Jeng‐Chang Chen	3
17	Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm 2004 ·Gastroenterology ·Shi‐Ming Lin, Chun‐Jung Lin, Chen‐Chun Lin, Chao‐Wei Hsu, Yi‐Cheng Chen	439
18	Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan 2002 ·Journal of Gastroenterology and Hepatology ·Chien‐Wei Su, Jaw‐Ching Wu, Yi‐Shin Huang, (unknown), Yi‐Hsiang Huang, Chen‐Chun Lin, Full‐Young Chang, Shou‐Dong Lee	14
19	Spread of hepatitis E virus among different‐aged pigs: two‐year survey in Taiwan 2002 ·Journal of Medical Virology ·Jaw‐Ching Wu, Chuan‐Mu Chen, Tzen‐Yuh Chiang, (unknown), Wen‐Juei Jeng, I‐Jane Sheen, Chen‐Chun Lin, Xiang‐Jin Meng	104
20	Hereditary hemorrhagic telangiectasia: Demonstration of portosystemic venous shunts using power Doppler sonography and sonographically guided percutaneous transhepatic portovenography 2001 ·Journal of Clinical Ultrasound ·Chen‐Chun Lin, Jaw‐Ching Wu, Yi‐Hong Chou, Yi‐Hsiang Huang, Full‐Young Chang, Shou‐Dong Lee	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact